These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8067714)

  • 1. Carcinoembryonic antigen (CEA) in serum and bile of colorectal cancer patients with or without detectable liver metastases.
    Paganuzzi M; Onetto M; de Paoli M; Castagnola M; de Salvo L; Civalleri D; Grossi CE
    Anticancer Res; 1994; 14(3B):1409-12. PubMed ID: 8067714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen concentration: a prospective study.
    Tuech JJ; Pessaux P; Regenet N; Daver A; Lorimier G; Bergamaschi R; Arnaud JP
    J Surg Oncol; 2004 Oct; 88(1):27-31. PubMed ID: 15384059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen.
    Novell F; Trias M; Molina R; Filella X
    Anticancer Res; 1997; 17(4A):2743-6. PubMed ID: 9252708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen to detect hepatic metastases of colorectal cancers.
    Kutun S; Celik A; Hatiboglu C; Ulucanlar H; Cetin A
    Surg Today; 2003; 33(8):590-4. PubMed ID: 12884096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary carcinoembryonic antigen levels can predict metachronous liver metastasis of colorectal cancer.
    Ishida H; Yoshinaga K; Gonda T; Ando M; Hojo I; Fukunari H; Iwama T; Mishima Y
    Anticancer Res; 2000; 20(1B):523-6. PubMed ID: 10769718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of occult liver metastases by measurement of biliary carcinoembryonic antigen concentrations.
    Paul MA; Visser JJ; Mulder C; Blomjous JG; van Kamp GJ; Cuesta MA; Meijer S
    Eur J Surg; 1996 Jun; 162(6):483-8. PubMed ID: 8817226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measurement of bile CEA levels in patients with colorectal cancer: is it of value for diagnosis of occult liver metastases aiming at prophylactic regional hepatic chemotherapy?].
    Ishida H; Hojo I; Gonda T; Nakajima H; Hirukawa H; Itoh M; Satoh K; Higuchi T; Toyooka M; Yoshinaga K
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1551-4. PubMed ID: 8373216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of biliary CEA in the diagnosis of colorectal cancer with liver metastases].
    Huang M; Tang D; Li B
    Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):45-7. PubMed ID: 11776796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary carcinoembryonic antigen in the diagnosis of occult hepatic metastases from colorectal cancer.
    Li Destri G; Curreri R; Lanteri R; Gagliano G; Rodolico M; Di Cataldo A; Puleo S
    J Surg Oncol; 2002 Sep; 81(1):8-11. PubMed ID: 12210019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary carcinoembryonic antigen levels in diagnosis of occult hepatic metastases from colorectal carcinoma.
    Waisberg J; Palma RT; Neto LC; Martins LC; Oliveira MS; Nagashima CA; Godoy AC; Goffi FS
    World J Gastroenterol; 2003 Jul; 9(7):1589-93. PubMed ID: 12854170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.
    Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR
    Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low preoperative serum carcinoembryonic antigen concentration is a marker of good prognosis in patients undergoing cryotherapy for low volume hepatic metastases from colorectal cancer.
    Seifert JK; Morris DL
    Int J Surg Investig; 2000; 2(4):327-34. PubMed ID: 12678536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can biliary carcinoembryonic antigen identify colorectal cancer patients with occult hepatic metastases?
    Li Destri G; Lanteri R; Santangelo M; Torrisi B; Di Cataldo A; Puleo S
    World J Surg; 2006 Aug; 30(8):1494-9. PubMed ID: 16847713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuech et al.: Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen concentration: a prospective study.
    Fielding LP
    J Surg Oncol; 2004 Nov; 88(2):108. PubMed ID: 15499600
    [No Abstract]   [Full Text] [Related]  

  • 15. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?
    Akdoğan M; Parlak E; Kayhan B; Balk M; Saydam G; Sahin B
    Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative carcinoembryonic antigen measurements to predict curability after liver resection for colorectal metastases: a prospective study.
    Oussoultzoglou E; Rosso E; Fuchshuber P; Stefanescu V; Diop B; Giraudo G; Pessaux P; Bachellier P; Jaeck D
    Arch Surg; 2008 Dec; 143(12):1150-8; discussion 1158-9. PubMed ID: 19075165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of CEA levels and positive cytology in peritoneal washings in patients with colorectal cancer.
    Kanellos I; Zacharakis E; Kanellos D; Pramateftakis MG; Betsis D
    Colorectal Dis; 2006 Jun; 8(5):436-40. PubMed ID: 16684089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma.
    Nakeeb A; Lipsett PA; Lillemoe KD; Fox-Talbot MK; Coleman J; Cameron JL; Pitt HA
    Am J Surg; 1996 Jan; 171(1):147-52; discussion 152-3. PubMed ID: 8554130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristic differences between patients who have undergone surgical treatment for lung metastasis or hepatic metastasis from colorectal cancer.
    Iwasaki A; Shirakusa T; Yamashita Y; Noritomi T; Maekawa T; Hamada T
    Thorac Cardiovasc Surg; 2005 Dec; 53(6):358-64. PubMed ID: 16311973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.